BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 31553483)

  • 21. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
    Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
    Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Succinate dehydrogenase deficiency in a PDGFRA mutated GIST.
    Belinsky MG; Cai KQ; Zhou Y; Luo B; Pei J; Rink L; von Mehren M
    BMC Cancer; 2017 Aug; 17(1):512. PubMed ID: 28768491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathology of gastrointestinal stromal tumors.
    Hirota S; Isozaki K
    Pathol Int; 2006 Jan; 56(1):1-9. PubMed ID: 16398673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic alterations in cell cycle regulation-associated genes may promote primary progression of gastrointestinal stromal tumors.
    Li P; Li M; Wang K; Liu Y; Wang Y; Zhao D; Chai J; Ma J; Li X; Wei J; Fan L; Zhang F; Ye J; Yan Q; Guo S; Wang Z
    Lab Invest; 2020 Mar; 100(3):426-437. PubMed ID: 31570771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying Secondary Mutations in Chinese Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors (GISTs) by Next Generation Sequencing (NGS).
    Du J; Wang S; Wang R; Wang SY; Han Q; Xu HT; Yang P; Liu Y
    Pathol Oncol Res; 2020 Jan; 26(1):91-100. PubMed ID: 31758409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour.
    Okamoto Y; Sawaki A; Ito S; Nishida T; Takahashi T; Toyota M; Suzuki H; Shinomura Y; Takeuchi I; Shinjo K; An B; Ito H; Yamao K; Fujii M; Murakami H; Osada H; Kataoka H; Joh T; Sekido Y; Kondo Y
    Gut; 2012 Mar; 61(3):392-401. PubMed ID: 21708825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of the RNA-binding protein RBPMS2 in gastrointestinal stromal tumors.
    Hapkova I; Skarda J; Rouleau C; Thys A; Notarnicola C; Janikova M; Bernex F; Rypka M; Vanderwinden JM; Faure S; Vesely J; de Santa Barbara P
    Exp Mol Pathol; 2013 Apr; 94(2):314-21. PubMed ID: 23295309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Histology and molecular biology of GIST].
    Emile JF
    Bull Acad Natl Med; 2012; 196(4-5):835-44. PubMed ID: 23550446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary gastrointestinal stromal tumors sharing the KIT Exon 17 germline mutation p.Asp820Tyr develop through different cytogenetic progression pathways.
    Veiga I; Silva M; Vieira J; Pinto C; Pinheiro M; Torres L; Soares M; Santos L; Duarte H; Bastos AL; Coutinho C; Dinis J; Lopes C; Teixeira MR
    Genes Chromosomes Cancer; 2010 Feb; 49(2):91-8. PubMed ID: 19847891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and pathological characteristics of gastrointestinal stromal tumor (GIST) metastatic to bone.
    Kosemehmetoglu K; Kaygusuz G; Fritchie K; Aydin O; Yapicier O; Coskun O; Karatayli E; Boyacigil S; Guler G; Dervisoglu S; Kuzu I
    Virchows Arch; 2017 Jul; 471(1):77-90. PubMed ID: 28488171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
    Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
    Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastrointestinal stromal tumor (GIST) pathogenesis, familial GIST, and animal models.
    Antonescu CR
    Semin Diagn Pathol; 2006 May; 23(2):63-9. PubMed ID: 17193819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential immune profiles distinguish the mutational subtypes of gastrointestinal stromal tumor.
    Vitiello GA; Bowler TG; Liu M; Medina BD; Zhang JQ; Param NJ; Loo JK; Goldfeder RL; Chibon F; Rossi F; Zeng S; DeMatteo RP
    J Clin Invest; 2019 May; 129(5):1863-1877. PubMed ID: 30762585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.
    Huss S; Elges S; Trautmann M; Sperveslage J; Hartmann W; Wardelmann E
    Expert Rev Anticancer Ther; 2015 Jun; 15(6):623-8. PubMed ID: 25831232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Duodenal SDH-Deficient Gastrointestinal Stromal Tumor in a Patient With a Germline SDHB Mutation.
    Elston MS; Sehgal S; Dray M; Phillips E; Conaglen JV; Clifton-Bligh RJ; Gill AJ
    J Clin Endocrinol Metab; 2017 May; 102(5):1447-1450. PubMed ID: 28324028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
    Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
    Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1.
    Stewart DR; Corless CL; Rubin BP; Heinrich MC; Messiaen LM; Kessler LJ; Zhang PJ; Brooks DG
    J Med Genet; 2007 Jan; 44(1):e61. PubMed ID: 17209131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Divergent gastrointestinal stromal tumors in syndromic settings.
    Ricci R; Martini M; Cenci T; Riccioni ME; Maria G; Cassano A; Larocca LM
    Cancer Genet; 2016; 209(7-8):354-8. PubMed ID: 27318444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
    Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM
    Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis.
    Yoon H; Tang CM; Banerjee S; Yebra M; Noh S; Burgoyne AM; Torre J; Siena M; Liu M; Klug LR; Choi YY; Hosseini M; Delgado AL; Wang Z; French RP; Lowy A; DeMatteo RP; Heinrich MC; Molinolo AA; Gutkind JS; Harismendy O; Sicklick JK
    Oncogene; 2021 Mar; 40(11):1957-1973. PubMed ID: 33603171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.